122 related articles for article (PubMed ID: 33309502)
1. Atypical bilateral presentation in idiopathic macular telangiectasia type 1.
Tapia Quijada HE; Mantolan Sarmiento C; Serrano García M; Betancor Caro N
Arch Soc Esp Oftalmol (Engl Ed); 2020 Dec; ():. PubMed ID: 33309502
[TBL] [Abstract][Full Text] [Related]
2. Atypical bilateral presentation in idiopathic macular telangiectasia type 1.
Tapia Quijada HE; Mantolan Sarmiento C; Serrano García M; Betancor Caro N
Arch Soc Esp Oftalmol (Engl Ed); 2021 Nov; 96(11):602-606. PubMed ID: 34756283
[TBL] [Abstract][Full Text] [Related]
3. Use of OCT Angiography to Diagnose and Manage Atypical Presentations of Macular Telangiectasia Type 2.
Moir J; Amin SV; Khanna S; Komati R; Shaw LT; Dao D; Hariprasad SM; Skondra D
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887197
[TBL] [Abstract][Full Text] [Related]
4. Multimodal Imaging Findings and Treatment with Dexamethasone Implant in Three Cases of Idiopathic Macular Telangiectasia Type 1.
Cirafici P; Musolino M; Saccheggiani M; Traverso CE; Nicolò M
Case Rep Ophthalmol; 2021; 12(1):92-97. PubMed ID: 33976663
[TBL] [Abstract][Full Text] [Related]
5. [Inefficacy of aflibercept in the treatment of idiopathic macular telangiectasia type 2 without neovascularization].
Bénichou J; Soler V; Denis D; Matonti F
J Fr Ophtalmol; 2017 Sep; 40(7):547-551. PubMed ID: 28803666
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of cystoid spaces in type 2 idiopathic macular telangiectasia on spectral domain optical coherence tomography images.
Oh JH; Oh J; Togloom A; Kim SW; Huh K
Retina; 2014 Jun; 34(6):1123-31. PubMed ID: 24240556
[TBL] [Abstract][Full Text] [Related]
7. Bilateral Type 1 Idiopathic Macular Telangiectasia in a Female Patient: Multimodal Imaging of a Rare Presentation.
Niyousha MR; Hassanpoor N; Jafari S
Case Rep Ophthalmol; 2021; 12(2):373-379. PubMed ID: 34054487
[TBL] [Abstract][Full Text] [Related]
8. OCT-angiography for diagnosis and response to treatment of subretinal neovascularization secondary to idiopathic macular telangiectasia type 2.
Tapia Quijada HE; Mantolan Sarmiento C; Gómez Perera S; Serrano García M; Betancor Caro N; Haro Álvarez B
Arch Soc Esp Oftalmol (Engl Ed); 2021 Jan; ():. PubMed ID: 33495053
[TBL] [Abstract][Full Text] [Related]
9. OCT-angiography for diagnosis and response to treatment of subretinal neovascularization secondary to idiopathic macular telangiectasia type 2.
Tapia Quijada HE; Mantolan Sarmiento C; Gómez Perera S; Serrano García M; Betancor Caro N; Haro Álvarez B
Arch Soc Esp Oftalmol (Engl Ed); 2022 Apr; 97(4):224-229. PubMed ID: 35523469
[TBL] [Abstract][Full Text] [Related]
10. Multimodal Imaging of Macular Telangiectasia Type 2: Focus on Vascular Changes Using Optical Coherence Tomography Angiography.
Toto L; Di Antonio L; Mastropasqua R; Mattei PA; Carpineto P; Borrelli E; Rispoli M; Lumbroso B; Mastropasqua L
Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT268-76. PubMed ID: 27409482
[TBL] [Abstract][Full Text] [Related]
11. Staging of macular telangiectasia: power-Doppler optical coherence tomography and macular pigment optical density.
Chin EK; Kim DY; Hunter AA; Pilli S; Wilson M; Zawadzki RJ; Werner JS; Park SS
Invest Ophthalmol Vis Sci; 2013 Jul; 54(7):4459-70. PubMed ID: 23716628
[TBL] [Abstract][Full Text] [Related]
12. Idiopathic macular telangiectasia type 2: A six-year study with multimodal imaging of a presumed unilateral case.
Zarei M; Mazloumi M; Karkhaneh R; Roohipoor R
J Curr Ophthalmol; 2018 Dec; 30(4):368-373. PubMed ID: 30555973
[TBL] [Abstract][Full Text] [Related]
13. Demographic features of idiopathic macular telangiectasia in Japanese patients.
Maruko I; Iida T; Sugano Y; Ojima A; Oyamada H; Sekiryu T
Jpn J Ophthalmol; 2012 Mar; 56(2):152-8. PubMed ID: 22219035
[TBL] [Abstract][Full Text] [Related]
14. MULTIMODAL IMAGING OF RECURRENT CYSTOID MACULAR EDEMA ASSOCIATED WITH POEMS SYNDROME RESPONSIVE TO INTRAVITREAL DEXAMETHASONE IMPLANT.
Pole C; Hosseini H; Prasad P
Retin Cases Brief Rep; 2022 Sep; 16(5):565-568. PubMed ID: 32969981
[TBL] [Abstract][Full Text] [Related]
15. Multimodal imaging of macular telangiectasia type 2 in a pediatric patient.
Moussa M; Leila M; Moussa O
Am J Ophthalmol Case Rep; 2021 Jun; 22():101082. PubMed ID: 33948521
[TBL] [Abstract][Full Text] [Related]
16. Does size of telangiectasia on optical coherence tomography angiography influence vision in eyes with type 2 macular telangiectasia?
Kelkar AS; Kelkar JA; Tidke S; Agarwal A; Bolisetty M; Kelkar S
Indian J Ophthalmol; 2021 Dec; 69(12):3570-3576. PubMed ID: 34826997
[TBL] [Abstract][Full Text] [Related]
17. Focal laser for idiopathic macular telangectasia type 1 refractory to ozurdex, ranibizumab and aflibercept.
Tapia Quijada HE; Gómez Perera S; Rodríguez Talavera I; Mantolan Sarmiento C; Rocha Cabrera P; Díaz de Aguilar Osona M; Serrano García M
Arch Soc Esp Oftalmol (Engl Ed); 2021 Mar; 96(3):162-166. PubMed ID: 32507720
[TBL] [Abstract][Full Text] [Related]
18. Macular Dystrophy with Bilateral Macular Telangiectasia Related to the CYP2U1 Pathogenic Variant Assessed with Multimodal Imaging Including OCT-Angiography.
El Matri K; Falfoul Y; Habibi I; Chebil A; Schorderet D; El Matri L
Genes (Basel); 2021 Nov; 12(11):. PubMed ID: 34828401
[TBL] [Abstract][Full Text] [Related]
19. Demographic features of idiopathic macular telangiectasia in Korean patients.
Kim SH; Oh J; Ahn SE; Park CY; Oh JH
Korean J Ophthalmol; 2015 Jun; 29(3):155-9. PubMed ID: 26028942
[TBL] [Abstract][Full Text] [Related]
20. Anti-retinal IgG antibodies in patients with early and advanced type 2 macular telangiectasia.
McLenachan S; Balaratnasingam C; Heath Jeffery RC; Chen SC; Zhang D; Chan G; Dolz-Marco R; Bacci T; Lo J; Wiffen S; Yannuzzi LA; Chen FK
Exp Eye Res; 2022 May; 218():109024. PubMed ID: 35271830
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
